Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

LaserSight Wins FDA Approval of Excimer System

Facebook Twitter LinkedIn Email Comments
WINTER PARK, Fla., Nov. 17 -- LaserSight Inc. reported that it has been granted pre-market approval by the US Food and Drug Administration for the use of its excimer laser system, the LaserScan LSX, in performing photorefractive keratectomy to treat low to moderate myopia. The approval will allow the company to market the system for laser refractive vision correction procedures in the US. LaserSight has also filed a PMA supplement for the use of the system to treat nearsightedness with astigmatism, and expects to file a PMA for hyperopia and hyperopic astigmatism in the middle of next year.
Nov 1999
News & Featureslasers

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.